Optimization of Orally Bioavailable Antileishmanial 2,4,5-Trisubstituted Benzamides.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.3c00056
Abstract: Leishmaniasis, a neglected tropical disease caused by Leishmania species parasites, annually affects over 1 million individuals worldwide. Treatment options for leishmaniasis are limited due to high cost, severe adverse effects, poor efficacy, difficulty of use,… read more here.
Keywords: chemistry; orally bioavailable; trisubstituted benzamides; antileishmanial trisubstituted ... See more keywords